As shown in Fig. 7a, LC patients accepting clinical antiviral treatment displayed a good outcome, indicated by significantly decreased Child-Pugh scores and total bilirubin (TBIL) concentration, increased serum albumin (ALB) levels and undetectable HBV load. The gene discussed is ALB; the disease is laryngotracheoesophageal cleft.